Reach out to our team anytime: To view or add a comment, sign in "Semaglutide, a GLP-1 medication initially used to treat diabetes, has a surprising side effect: significant weight loss
Safety, Sourcing, and Why Medical Oversight Is Non-Negotiable BPC-157 has a strong safety record in animal studies notably, the lethal dose (LD1) has not been achieved across decades of preclinical research, and it has been used in human ulcerative colitis and multiple sclerosis trials without reported toxicity.6 But the absence of adverse events in animals does not translate directly to human safety, particularly at unregulated doses from unverified sources
A higher ratio of apoB to apoA1 is a recognized risk factor for cardiovascular disease (Walldius and Jungner 2006)
Sermorelin and Ipamorelin administration Sermorelin is a large amino acid and thus can only be administered through injection
Glutathione inhibits the actual production as well as agglutination of melanin by interrupting the function of L-DOPA
The research community is running ahead of the clinical validation process, and that creates risk